Targeting SAMD1 enhances the effect of anti-PD-1 plus lenvatinib therapy in hepatocellular carcinoma by increasing ferroptosis sensitivity and immune response

作者：Guo-Qiang Pan, Yu‐Chuan Yan, Rui‐Zhe Li, Xiong Chen, Shao-peng Zhang, Yang Qu, Rui Dong, Yu Zhou, Tuan-Song Zhang, Zhiqiang Chen, Xiaolu Zhang, Xiao-Feng Dong, Dongxu Wang, Zhao‐Ru Dong, Tao Li · 发表于：Metabolism · 年份：2025 · DOI：10.1016/j.metabol.2025.156304 · 被引用次数：11 · 研究领域：Ferroptosis and cancer prognosis、Hippo pathway signaling and YAP/TAZ、Cancer Mechanisms and Therapy